Skip to search formSkip to main contentSkip to account menu

yttrium Y 90 monoclonal antibody BrE-3

Known as: Y90 MOAB BrE-3, monoclonal antibody BrE-3, yttrium Y 90, Y90 monoclonal antibody BrE-3 
A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A key challenge for the development of active plasmonic nanodevices is the lack of materials with fully controllable plasmonic… 
2011
2011
The synthesis, structure, and reactivity of the yttrium anilido hydride [LY(NH(DIPP))(μ-H)]2 (3; L = [MeC(N(DIPP))CHC(Me… 
2009
2009
The phase diagram of the binary Y 2 O 3 -B 2 O 3 system has been revised, the phase diagram in the pseudo-binary YAlO 3 - YB0 3… 
2005
2005
Low high-density lipoprotein-cholesterol (HDL-c) is an important risk factor of coronary artery disease (CAD). Optimum therapy… 
1995
1995
The structural and electronic properties of yttrium trihydride with metal atoms in the hexagonal-close-packed (hcp) structure are… 
1994
1994
열분해법을 이용하여, 양이온 비가 Bi : Y : Fe = 1.5 + u : 1.5 : 5 및 Bi : Y : Fe = 1.5: 1.5 + v : 5 (-0.7 ≤ u ≤ 1.0, -0.7 ≤ v ≤ 1.3… 
1960
1960
Recent developments in yttrium hydride research have made available a material with exceptional high-temperature properties. The…